ArticleScientific reports2026
Transcriptional remodeling of cardiomyocytes and fibroblasts during post-myocardial infarction recovery.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Myocardial infarction (MI) results from reduced coronary blood flow, leading to oxygen deprivation and impaired systolic and diastolic function, which increases the risk of cardiac arrhythmias. Various cardiac cell types respond to this stress to preserve heart function, but the precise, cell-type-specific mechanisms remain poorly understood. To investigate these responses, we performed single-nucleus RNA sequencing (snRNA-seq) on left ventricular tissue from mouse hearts at baseline (Day 0) and at 1 and 4 weeks post-MI. This enabled us to characterize transcriptional changes across major cardiac cell types. We observed significant shifts in the transcriptional states of cardiomyocytes (CMs) and fibroblasts (FBs) cell populations following MI. CMs showed a major transcriptional modulation from healthy to diseased state during early chronic phase of post-MI, however, the recovery phenotype was observed during the late chronic phase, suggesting a natural compensatory response of CMs against the ischemic stress. FBs exhibited dynamic transcriptional changes consistent with roles in post-MI healing and fibrosis. In addition, inferred alterations in cell-cell communication networks highlighted changes in intercellular signaling pathways, shedding light on disrupted crosstalk in the injured heart. Together, our findings provide a comprehensive transcriptional landscape of cardiac cell populations, especially CMs and FBs, following MI and identify potential molecular targets for therapeutic intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.